Table 1.
Baseline characteristics of all participants and participants who dropped out after the baseline questionnaire
| Participants with completed follow-up (n=165) |
Drop out after baseline (n=86) |
P value | |
| Age (mean±SD) | 66.7±9.7 | 65.4±12.1 | 0.42* |
| Prescription from GP (%) | 86.3 | 83.2 | 0.55† |
| IPSS (mean±SD) | 19.1±6.8 | 17.6±6.5 | 0.11* |
| IPSS categories (%) | 0.12 | ||
| None/mild | 3.7 | 6.4 | |
| Moderate | 50.9 | 61.5 | |
| Severe | 45.3 | 32.1 | |
| IPSS quality of life (median | IQR) | 4.0 | 3.0–5.0 | 4.0 | 3.0–5.0 | 0.52‡ |
| OAB-q SF (mean±SD) | 39.8±19.2 | 40.7±18.1 | 0.70* |
| Duration of LUTS in months (median | IQR) | 24.0 | 5.0–42.0 | 12.0 | 3.0–36.0 | 0.11‡ |
| History of surgery for LUTS (%) | 1.2 | 3.8 | 0.19† |
*Student’s t-test.
†χ2 test.
‡Mann-Whitney U test.
GP, General practitioner; IPSS, International Prostate Symptom Score; IQR, Interquartile Range; LUTS, lower urinary tract symptoms; OAB-q SF, Overactive Bladder Questionnaire short form.